World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
116153
World Ranking
573
National Ranking
16

Medicine

D-Index
105
Citations
116547
World Ranking
6628
National Ranking
188

Guy B. Marks publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guy B. Marks sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 579 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Guy B. Marks D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guy B. Marks sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Guy B. Marks is affiliated with the University of New South Wales in Australia and has contributed extensively to the field of medicine, with a particular focus on respiratory and infectious diseases. Their research spans several key subfields including pulmonary and respiratory medicine, infectious diseases, health toxicology and mutagenesis, physiology, and epidemiology.

The scientist has published notable papers addressing various critical topics in respiratory health and infectious diseases. Among these are:

  • How can airborne transmission of COVID-19 indoors be minimised? (2020) in Environment International
  • Improving lung health in low-income and middle-income countries: from challenges to solutions (2021) in The Lancet
  • Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study (2021) in The Lancet
  • A paradigm shift to combat indoor respiratory infection (2021) in Science
  • Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals (2020) in Critical Care Medicine

Their main research topics include:

  • Tuberculosis research and epidemiology
  • Asthma and respiratory diseases
  • Air quality and health impacts
  • Climate change and health impacts
  • Chronic obstructive pulmonary disease (COPD) research
  • Respiratory and cough-related research
  • Pneumocystis jirovecii pneumonia detection and treatment

Frequent co-authors that have worked alongside Guy B. Marks include:

  • Greg J. Fox
  • Thu Anh Nguyen
  • Brett G. Toelle
  • Lídia Morawska
  • Frances Garden

The scientist's work has appeared repeatedly in various publication venues. The most frequent among them are:

  • The International Journal of Tuberculosis and Lung Disease
  • SSRN Electronic Journal
  • ISEE Conference Abstracts
  • Respirology
  • bioRxiv (Cold Spring Harbor Laboratory)

Guy B. Marks' research contributions predominantly lie within medicine, specifically focusing on respiratory issues and infectious diseases, reflecting a broad and interdisciplinary approach to lung health and epidemiological challenges. Their ongoing involvement in these areas aligns with efforts to understand and mitigate respiratory illness burdens worldwide.

Best Publications

  • Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

    Rafael Lozano;Mohsen Naghavi;Kyle Foreman;Stephen Lim

  • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

    Christopher J.L. Murray;Theo Vos;Rafael Lozano;Mohsen Naghavi

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Gregory A Roth;Gregory A Roth;Degu Abate;Kalkidan Hassen Abate;Solomon M Abay

  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

    Theo Vos;Abraham D. Flaxman;Mohsen Naghavi;Rafael Lozano

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    Mohammad H Forouzanfar;Lily Alexander;H Ross Anderson;Victoria F Bachman

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

    Theo Vos;Ryan M. Barber;Brad Bell;Amelia Bertozzi-Villa

  • Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    Mohsen Naghavi;Haidong Wang;Rafael Lozano;Adrian Davis

  • International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study

    A Sonia Buist;Mary Ann McBurnie;William M. Vollmer;Suzanne Gillespie

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013

    Mohammad H. Forouzanfar;Lily Alexander;H. Ross Anderson;Victoria F. Bachman

  • How can airborne transmission of COVID-19 indoors be minimised?

    Lidia Morawska;Julian W. Tang;William Bahnfleth;Philomena M. Bluyssen

  • After asthma: redefining airways diseases

    Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson

  • A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis

    Mark R. Elkins;Michael Robinson;Barbara R. Rose;Colin Harbour

  • Contact investigation for tuberculosis: a systematic review and meta-analysis.

    Gregory J. Fox;Simone E. Barry;Warwick J. Britton;Warwick J. Britton;Guy B. Marks;Guy B. Marks

  • Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    David J. Lederer;Scott C. Bell;Richard D. Branson;James D. Chalmers

  • Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

    Haileyesus Getahun;Alberto Matteelli;Ibrahim Abubakar;Mohamed Abdel Aziz

  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

    Haidong Wang;Amanuel Alemu Abajobir;Kalkidan Hassen Abate;Cristiana Abbafati

  • Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis

    Lavinia Paternoster;Marie Standl;Johannes Waage;Hansjoerg Baurecht

  • Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial

    Peter G Gibson;Peter G Gibson;Ian A Yang;John W Upham;John W Upham;Paul N Reynolds;Paul N Reynolds

  • Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization

    Gennaro D'Amato;Stephen T Holgate;Ruby Pawankar;Dennis K Ledford

  • Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015

    Ryan M Barber;Nancy Fullman;Reed J D Sorensen;Thomas Bollyky

  • Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.

    Craig L. Phillips;Ronald R. Grunstein;M. Ali Darendeliler;Anastasia S. Mihailidou

Frequent Co-Authors

Euan R. Tovey
Euan R. Tovey Woolcock Institute of Medical Research
Peter G. Gibson
Peter G. Gibson University of Newcastle Australia
Helen K. Reddel
Helen K. Reddel Woolcock Institute of Medical Research
David S. Celermajer
David S. Celermajer Royal Prince Alfred Hospital
Warwick J. Britton
Warwick J. Britton University of Sydney
Catarina Almqvist
Catarina Almqvist Karolinska Institute
Michael J. Abramson
Michael J. Abramson Monash University
John W. Upham
John W. Upham University of Queensland
Lidia Morawska
Lidia Morawska Queensland University of Technology
Paul N. Reynolds
Paul N. Reynolds University of Adelaide

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career opportunities in healthcare and research. Many professionals consider specializing in nursing roles that complement Immunology, such as Psychiatric-Mental Health Nurse Practitioner, where affordable options are available through some of the cheapest online pmhnp certificate programs.

Advancing education with a Doctor of Nursing Practice (DNP) degree can greatly impact earning potential and career growth. Understanding the doctor of nursing practice salary by state helps students make informed decisions about where to study and work post-graduation.

For those already certified as Family Nurse Practitioners (FNPs), transitioning to more specialized roles in acute care is a popular pathway. Guidance on how to effectively make this shift is detailed in resources about the fnp to acnp transition, offering a roadmap for expanding clinical expertise.

Many aspiring nurse practitioners benefit from enrollment in accelerated np programs that allow for faster completion and quicker entry into the workforce, which is particularly valuable for those motivated to combine nursing with Immunology-focused care and research roles.

Best Scientists Citing Guy B. Marks

Trending Scientists

Recently Published Articles